BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2769694)

  • 21. Transfer of persulfide sulfur from thiocystine to rhodanese.
    Abdolrasulnia R; Wood JL
    Biochim Biophys Acta; 1979 Mar; 567(1):135-43. PubMed ID: 454618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oxygen on the antagonism of cyanide intoxication: cytochrome oxidase, in vitro.
    Isom GE; Way JL
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):57-62. PubMed ID: 6328698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfides as cyanide antidotes: evidence for a new in vivo oxidative pathway for cyanide detoxification.
    Zottola MA; Beigel K; Soni SD; Lawrence R
    Chem Res Toxicol; 2009 Dec; 22(12):1948-53. PubMed ID: 19891443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphic Variants of Human Rhodanese Exhibit Differences in Thermal Stability and Sulfur Transfer Kinetics.
    Libiad M; Sriraman A; Banerjee R
    J Biol Chem; 2015 Sep; 290(39):23579-88. PubMed ID: 26269602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of the N-bromosuccinimide inactivation of the enzyme rhodanese.
    Guido K; Horowitz P
    Biochim Biophys Acta; 1977 Nov; 485(1):95-100. PubMed ID: 911868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased thiosulfate sulfur transferase (rhodanese) in Leber's hereditary optic atrophy.
    Cagianut B; Schnebli HP; Rhyner K; Furrer J
    Klin Wochenschr; 1984 Sep; 62(18):850-4. PubMed ID: 6593495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effect of cyanide, thiosulphate and S-adenosyl-L-methionine on the activity of rhodanese and other enzymes.
    Buzaleh AM; Vazquez ES; Del Carmen Batlle AM
    Gen Pharmacol; 1991; 22(2):281-6. PubMed ID: 1647344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification.
    Nagahara N; Ito T; Minami M
    Histol Histopathol; 1999 Oct; 14(4):1277-86. PubMed ID: 10506943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of rhodanese.
    Sylvester M; Sander C
    Histochem J; 1990 Apr; 22(4):197-200. PubMed ID: 2387754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the catalytic activity of rhodanese by S-nitrosylation using nitric oxide donors.
    Kwiecień I; Sokołowska M; Luchter-Wasylewska E; Włodek L
    Int J Biochem Cell Biol; 2003 Dec; 35(12):1645-57. PubMed ID: 12962704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyanide intoxication--III. On the analogous and different effects provoked by non-lethal and lethal challenged doses.
    Buzaleh AM; Vazquez ES; del Carmen Batlle AM
    Gen Pharmacol; 1990; 21(1):27-32. PubMed ID: 2153608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational changes accompany the oxidative inactivation of rhodanese by a variety of reagents.
    Horowitz PM; Bowman S
    J Biol Chem; 1987 Jun; 262(18):8728-33. PubMed ID: 3474229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of metal cyanide complexes to bovine liver rhodanese in the crystalline state.
    Lijk LJ; Kalk KH; Brandenburg NP; Hol WG
    Biochemistry; 1983 Jun; 22(12):2952-7. PubMed ID: 6575830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the binding of sulfate, selenate and thiosulfate ions to bovine liver rhodanese, and a description of a binding site for ammonium and sodium ions. An X-ray diffraction study.
    Lijk LJ; Torfs CA; Kalk KH; De Maeyer MC; Hol WG
    Eur J Biochem; 1984 Jul; 142(2):399-408. PubMed ID: 6589161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo studies on rhodanese encapsulation in mouse carrier erythrocytes.
    Leung P; Cannon EP; Petrikovics I; Hawkins A; Way JL
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):268-74. PubMed ID: 1891774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation of thiosulfate: cyanide sulfurtransferase by mouse erythrocytes.
    Leung P; Ray LE; Sander C; Way JL; Sylvester DM; Way JL
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):101-7. PubMed ID: 3456651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of rhodanese from human gastric mucosa and stomach adenocarcinoma by 2,4, 6-trinitrobenzenesulphonate and by 4,4'-diisothiocyanatostilbene-2,2'-disulphonate.
    Malliopoulou VA; Rakitzis ET; Malliopoulou TB
    Anticancer Res; 1989; 9(4):1133-6. PubMed ID: 2817794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo comparison of sulfur donors as antidotes to acute cyanide intoxication.
    Baskin SI; Porter DW; Rockwood GA; Romano JA; Patel HC; Kiser RC; Cook CM; Ternay AL
    J Appl Toxicol; 1999; 19(3):173-83. PubMed ID: 10362268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of rhodanese and organic thiosulfonates by mouse erythrocytes.
    Petrikovics I; Pei L; McGuinn WD; Cannon EP; Way JL
    Fundam Appl Toxicol; 1994 Jul; 23(1):70-5. PubMed ID: 7958565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-intercalated rhodanese in cyanide antagonism.
    Petrikovics I; Baskin SI; Beigel KM; Schapiro BJ; Rockwood GA; Manage AB; Budai M; Szilasi M
    Nanotoxicology; 2010 Jun; 4(2):247-54. PubMed ID: 20795898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.